Medical

We emphasize a minimally invasive approach, as opposed to a maximally invasive approach (ie. Major surgery). Our underlying objectives are:

  • To operate a customer-focused company based upon engineering innovation, clinical expertise and the dedication of all personnel.
  • To create and continuously support a work environment fostering the ‘3I’ (Initiate - Innovate - Improve) iterative process to the development cycle.
  • To provide sound evidence of the health and cost benefits associated with the use of our products.
  • To recognize, develop and motivate the talents and expertise of our engineering, medical and technical staff as they strive for continuous innovation and excellence.
  • To establish and maintain a comprehensive, company-wide quality management system (QMS) to meet customer expectations and regulatory requirements.
  • To conduct company business in a professional and ethical manner.

Upon establishing the Medical Device integrated manufacturing facility in Richmond British Columbia, the company plans to continue sales of several products currently manufactured in MIMA-Pro China facility and realize new, novel products while expanding its general operational and technical capabilities. These efforts will lead to an initial two-tiered business platform focusing on opportunities in: interventional oncology; and surgical hemostasis gathered from MIMA Pro’s extensive clinical network in world.

MIMA Pro has inherited and possess the Intellectual Property of inventions of microwave-based therapeutic technologies. MIMA Pro's technology foundation  is derived from research & development, production, and sales of medical microwave apparatus since 2010. Through continuous improvements to the safety and effectiveness of its technology near 10 years, MIMA Pro products offer superior performance and can claim inventor-ship of:

  • Interference-free High-precision Temperature Measurement Technique" and;
  • High-precision Dynamic Microwave Power Stability System;
  • Water-cooled Microwave Ablation System;
  • High-power Pulsed Microwave Modulation Technique;
  • MRI Compatible Microwave System.

 

MIMA-Pro's HealthCare Technology Development and Knowledge Acquisition  History

  • 2009 - Investigation and development of  the "Microwave Tumor Ablation System"
  • 2012 - Launch of the new generation "High-power and efficient water-cooled microwave ablation system"
  • 2014 -  Development of 18/19 Gauge, water-cooled probe,
  • 2015 -  Launched first in world 2.45 GHz MRI compatible system.
  • 2016 -  Released low cost, robust solid state 2.45 GHz Generator